Pancreatic Cancer Research

ResearcherTexas A&M UniversityActive in the last 2 years

Stephen H Safe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-2115-3060; OpenAlex author ID A5036575223; NIH RePORTER profile ID 1870620. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 12)
Trials
0
Grants
2
Labs led
2
Collaborators
21
Papers, trials and grants by year

2011: 1 paper, 1 grant · 2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper, 1 grant · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 4 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 17

  1. Editorial: Emerging anti-cancer compounds and immunomodulators for pancreatic cancer treatment. First author DOI 10.3389/fonc.2024.1411836↗
  2. Citrus limonoids induce apoptosis and inhibit the proliferation of pancreatic cancer cells. Co-author DOI 10.1039/d0fo02740e↗
  3. Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/2767-9764.crc-21-0073↗
  4. Broussochalcone A Is a Novel Inhibitor of the Orphan Nuclear Receptor NR4A1 and Induces Apoptosis in Pancreatic Cancer Cells. Co-author DOI 10.3390/molecules26082316↗
  5. Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer. Co-author DOI 10.3748/wjg.v27.i38.6387↗
  6. Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK. Last author DOI 10.1016/j.bbrc.2018.05.061↗
  7. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer. Last author DOI 10.1371/journal.pone.0192264↗
  8. Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells. First author DOI 10.1016/j.taap.2017.07.017↗
  9. Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Can… Last author DOI 10.1074/jbc.m116.746339↗
  10. Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway. Last author DOI 10.1021/tx5005198↗
  11. The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. Last author DOI 10.18632/oncotarget.3450↗
  12. Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) tra… Last author DOI 10.1074/jbc.m114.592576↗
  13. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Last author DOI 10.1158/1541-7786.mcr-13-0567↗
  14. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Last author DOI 10.1038/onc.2012.193↗
  15. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Last author DOI 10.1093/carcin/bgt231↗
  16. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells. Last author DOI 10.1016/j.bcp.2012.02.021↗
  17. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors. Last author DOI 10.1093/carcin/bgr040↗

Grants 2

  1. Cytosolic Ah Receptor: Mechanism of Action R21ES025839↗
  2. NUR77 Agonists: New Targets for Pancreatic Cancer Chemotherapy R01CA124998↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Syng‐Ook Lee · 5 shared papers, 2011–2021 · strength 0.41
  2. Kathleen E. DelGiorno · 1 shared paper, 2024 · strength 0.36
  3. Jennifer M. Bailey · 1 shared paper, 2024 · strength 0.36
  4. Un-Ho Jin · 4 shared papers, 2014–2018 · strength 0.32
  5. Hyo-Seon Lee · 2 shared papers, 2017–2021 · strength 0.29
  6. Maen Abdelrahim · 3 shared papers, 2013–2021 · strength 0.24
  7. Bhimanagouda S. Patil · 1 shared paper, 2021 · strength 0.19
  8. Kotamballi N. Chidambara Murthy · 1 shared paper, 2021 · strength 0.19
  9. Yating Cheng · 2 shared papers, 2015–2018 · strength 0.14
  10. Sneha H. Johnson · 1 shared paper, 2021 · strength 0.12
  11. Mahsa Zarei · 1 shared paper, 2021 · strength 0.12
  12. Ali Vaziri Gohar · 1 shared paper, 2021 · strength 0.12
  13. Mehrdad Zarei · 1 shared paper, 2021 · strength 0.12
  14. Vijayalekshmi Nair · 2 shared papers, 2013–2014 · strength 0.09
  15. Riyaz M. Basha · 2 shared papers, 2013–2014 · strength 0.09
  16. Ravi Kasiappan · 1 shared paper, 2016 · strength 0.08
  17. Kyounghyun Kim · 2 shared papers, 2011–2013 · strength 0.07
  18. Xi Li · 1 shared paper, 2012 · strength 0.05
  19. Ju-Seog Lee · 1 shared paper, 2014 · strength 0.04
  20. Sung‐Hoon Kim · 1 shared paper, 2013 · strength 0.04
  21. Kyungsil Yoon · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.